Literature DB >> 7427134

Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.

K H Nilsen, M I Jayson.   

Abstract

The cutaneous microcirculation in the hand was measured in 23 patients with systemic sclerosis, 19 with Raynaud's phenomenon and four without Raynaud's phenomenon, and 20 controls. The patients with Raynaud's phenomenon had a reduced basal blood flow and an exaggerated further reduction on local cold stimulation, though both were normal in patients without Raynaud's phenomenon. Reflex-induced vascular changes by cold stimulation of the contralateral hand showed no differences between the three groups. The blood flows were similar in the affected skin of the anterior chest wall in four patients with systemic sclerosis and peripheral Raynaud's phenomenon and matched controls. In the seven most severely affected patients 1 mg of intra-arterial reserpine produced a prompt improvement in the cutaneous microcirculation which usually lasted one to three weeks but occasionally much longer. By judicious use of repeated injection guided by measurements of the microcirculation it was possible to heal indolent ulcers of the fingers. The results indicate that vascular changes are common in systemic sclerosis but are not fundamental in the pathogenesis of the disease. More probably there is a general soft tissue abnormality that usually but not necessarily affects the vessels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7427134      PMCID: PMC1601747          DOI: 10.1136/bmj.280.6229.1408

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Pathogenesis of systemic sclerosis: a vascular hypothesis.

Authors:  P M Campbell; E C LeRoy
Journal:  Semin Arthritis Rheum       Date:  1975-05       Impact factor: 5.532

2.  Intra-arterially administered reserpine and saline in scleroderma.

Authors:  R C Siegel; J F Fries
Journal:  Arch Intern Med       Date:  1974-09

3.  Medical uses of intra-arterial injections of reserpine. Treatment of Raynaud syndrome and of some vascular insufficiencies of the lower extremities.

Authors:  J P Tindall; R E Whalen; E E Burton
Journal:  Arch Dermatol       Date:  1974-08

4.  Intraarterial reserpine administration in Raynaud syndrome.

Authors:  I J McFadyen; E Housley; A I MacPherson
Journal:  Arch Intern Med       Date:  1973-10

5.  Digital arteries in patients with scleroderma. Arteriographic and plethysmographic study.

Authors:  L Dabich; J J Bookstein; A Zweifler; C J Zarafonetis
Journal:  Arch Intern Med       Date:  1972-11

6.  Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection.

Authors:  J T Willerson; R H Thompson; P Hookman; J Herdt; J L Decker
Journal:  Ann Intern Med       Date:  1970-01       Impact factor: 25.391

7.  Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon.

Authors:  S G Romeo; R E Whalen; J P Tindall
Journal:  Arch Intern Med       Date:  1970-05

8.  Abnormal blood viscosity in Raynaud's phenomenon.

Authors:  K B Goyle; J A Dormandy
Journal:  Lancet       Date:  1976-06-19       Impact factor: 79.321

9.  Assessment of cold sensitivity in Raynaud's phenomenon associated with scleroderma.

Authors:  K H Nilsen
Journal:  Microvasc Res       Date:  1978-03       Impact factor: 3.514

10.  Reserpine treatment of Raynaud's disease.

Authors:  B A Nobin; S L Nielsen; B Eklov; N A Lassen
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969

View more
  2 in total

1.  PGE1 and vasospastic disease.

Authors:  V Spence
Journal:  Br Med J       Date:  1980-11-29

Review 2.  Systemic sclerosis--a microvascular disorder?

Authors:  M I Jayson
Journal:  J R Soc Med       Date:  1983-08       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.